CHST12: a potential prognostic biomarker related to the immunotherapy response in pancreatic adenocarcinoma

Overview of attention for article published in Frontiers in endocrinology, January 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 1 X post from an account with 4,827 followers.

New Research: CHST12: a potential prognostic biomarker related to the immunotherapy response in pancreatic adenocarcinoma: Background Pancreatic adenocarcinoma (PAAD) is characterized by lower immunogenicity with a poor response… https://t.co/oh8uKJEg7G #

25 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.